Gillian Ellison

2.4k total citations · 1 hit paper
20 papers, 1.7k citations indexed

About

Gillian Ellison is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gillian Ellison has authored 20 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 9 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gillian Ellison's work include Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (9 papers) and BRCA gene mutations in cancer (5 papers). Gillian Ellison is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (9 papers) and BRCA gene mutations in cancer (5 papers). Gillian Ellison collaborates with scholars based in United Kingdom, Singapore and Italy. Gillian Ellison's co-authors include Georgina Speake, Guanshan Zhu, Rose McCormack, Emma Donald, Simon Dearden, Claire Watkins, Angela V. Flannery, Fred R. Hirsch, Wilbur A. Franklin and Nick Thatcher and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Gillian Ellison

20 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer

2006 570 citations Fred R. Hirsch, Marileila Varella‐Garcia et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gillian Ellison United Kingdom	13	1.0k	924	630	620	160	20	1.7k
Christopher J. Lafargue United States	16	825 0.8×	640 0.7×	567 0.9×	947 1.5×	131 0.8×	30	1.8k
Lynda Grinsted United Kingdom	11	730 0.7×	850 0.9×	376 0.6×	703 1.1×	171 1.1×	19	1.4k
Georgiana Kuhlmann United States	5	920 0.9×	753 0.8×	357 0.6×	500 0.8×	50 0.3×	6	1.3k
Francesco Pepe Italy	23	890 0.9×	723 0.8×	719 1.1×	531 0.9×	61 0.4×	108	1.5k
Jacqui Rowbottom United Kingdom	10	791 0.8×	1.2k 1.3×	321 0.5×	567 0.9×	215 1.3×	14	1.6k
Diana B. Cherbavaz United States	16	704 0.7×	402 0.4×	838 1.3×	373 0.6×	163 1.0×	33	1.6k
Eva Carrasco Spain	22	476 0.5×	1.5k 1.6×	1.1k 1.8×	358 0.6×	302 1.9×	77	2.0k
Stephen P. Anthony United States	14	368 0.4×	881 1.0×	603 1.0×	482 0.8×	103 0.6×	53	1.5k
Aleksandra Markovets United States	3	999 1.0×	825 0.9×	652 1.0×	869 1.4×	102 0.6×	6	1.7k
Karolina Holm Sweden	13	434 0.4×	803 0.9×	631 1.0×	1.4k 2.3×	203 1.3×	20	2.0k

Countries citing papers authored by Gillian Ellison

Since Specialization

Citations

This map shows the geographic impact of Gillian Ellison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Ellison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Ellison more than expected).

Fields of papers citing papers by Gillian Ellison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Ellison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Ellison. The network helps show where Gillian Ellison may publish in the future.

Co-authorship network of co-authors of Gillian Ellison

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Ellison. A scholar is included among the top collaborators of Gillian Ellison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Ellison. Gillian Ellison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cairns, Jonathan, Susan J. Monkley, B. Angermann, et al.. (2023). DOP06 Deep characterization of IL-23 pathway in different gut segments and associated plasma biomarkers in inflammatory bowel disease. Journal of Crohn s and Colitis. 17(Supplement_1). i64–i67. 1 indexed citations

Ellison, Gillian, Andrew J. Wallace, Alexander Kohlmann, & Simon Patton. (2017). A comparative study of germline BRCA1 and BRCA2 mutation screening methods in use in 20 European clinical diagnostic laboratories. British Journal of Cancer. 117(5). 710–716. 7 indexed citations

Capoluongo, Ettore, Gillian Ellison, José Antonio López‐Guerrero, et al.. (2017). Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients. Seminars in Oncology. 44(3). 187–197. 70 indexed citations

Wu, Xiaohua, Lingying Wu, Beihua Kong, et al.. (2017). The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients. International Journal of Gynecological Cancer. 27(8). 1650–1657. 55 indexed citations

Garrec, Céline, D. Goossens, Gillian Ellison, et al.. (2016). Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples. Oncotarget. 7(49). 81357–81366. 9 indexed citations

Ellison, Gillian, Shuwen Huang, T. Hedley Carr, et al.. (2015). A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing. BMC Clinical Pathology. 15(1). 5–5. 41 indexed citations

Donald, Emma, Gillian Ellison, Sarah R. Bujac, et al.. (2014). Analytical Validation of BRAF Mutation Testing from Circulating Free DNA Using the Amplification Refractory Mutation Testing System. Journal of Molecular Diagnostics. 16(3). 343–349. 38 indexed citations

Liu, Xiaoqing, Yachao Lu, Guanshan Zhu, et al.. (2013). The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies. Journal of Clinical Pathology. 66(12). 1065–1069. 125 indexed citations

Ellison, Gillian, et al.. (2012). EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples. Journal of Clinical Pathology. 66(2). 79–89. 235 indexed citations

10.

Ellison, Gillian, et al.. (2012). The professional practice of educational psychologists: Developing narrative approaches. Educational and Child Psychology. 29(2). 41–52. 6 indexed citations

11.

Ellison, Gillian, Emma Donald, Gael McWalter, et al.. (2010). A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples. Journal of Experimental & Clinical Cancer Research. 29(1). 132–132. 132 indexed citations

12.

Board, Ruth, Gillian Ellison, Emma Donald, et al.. (2010). Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours. PubMed. 4(1-4). 11–21. 36 indexed citations

13.

Ellison, Gillian, et al.. (2010). Circulating free DNA as a surrogate for tumor material for EGFR and KRAS analysis. Clinical Cancer Research. 16(19_Supplement). PR4–PR4. 1 indexed citations

14.

Board, Ruth, Gillian Ellison, Maria Orr, et al.. (2009). Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study. British Journal of Cancer. 101(10). 1724–1730. 78 indexed citations

15.

Hirsch, Fred R., Marileila Varella‐Garcia, Paul A. Bunn, et al.. (2006). Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 24(31). 5034–5042. 570 indexed citations breakdown →

16.

Ellison, Gillian. (2002). Further evidence to support the melanocytic origin of MDA-MB-435. Molecular Pathology. 55(5). 294–299. 139 indexed citations

17.

Bull, John H., Gillian Ellison, Anup Patel, et al.. (2001). Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray. British Journal of Cancer. 84(11). 1512–1519. 93 indexed citations

18.

Fox, Jayne C., Peter S. White, Gillian Ellison, et al.. (1998). The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system. British Journal of Cancer. 77(8). 1267–1274. 33 indexed citations

19.

Ellison, Gillian. (1997). Witnessed resuscitation: the relatives’ experience. Emergency Nurse. 5(8). 27–29. 4 indexed citations

20.

Neville, E, Gillian Ellison, Hippokratis Kiaris, et al.. (1995). DETECTION OF K-RAS MUTATIONS IN NONSMALL CELL LUNG-CARCINOMA. International Journal of Oncology. 7(3). 511–4. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact